Puja Pathuri
Plex Pharmaceuticals (United States)(US)GW Pharmaceuticals (United Kingdom)(GB)
Publications by Year
Research Areas
Computational Drug Discovery Methods, Melanoma and MAPK Pathways, S100 Proteins and Annexins, Synthesis and biological activity, Monoclonal and Polyclonal Antibodies Research
Most-Cited Works
- → Discovery of an allosteric mechanism for the regulation of HCV NS3 protein function(2012)112 cited
- → Structure of the Epigenetic Oncogene MMSET and Inhibition by N-Alkyl Sinefungin Derivatives(2016)67 cited
- → Fragment-Based Discovery of a Potent, Orally Bioavailable Inhibitor That Modulates the Phosphorylation and Catalytic Activity of ERK1/2(2018)65 cited
- → Fragment-to-Lead Medicinal Chemistry Publications in 2022(2024)40 cited
- → Crystal Structure of Metastasis-Associated Protein S100A4 in the Active Calcium-Bound Form(2008)38 cited
- → Fragment-Based Discovery of 6-Azaindazoles As Inhibitors of Bacterial DNA Ligase(2013)23 cited
- → Apo and Calcium-Bound Crystal Structures of Cytoskeletal Protein Alpha-14 Giardin (Annexin E1) from the Intestinal Protozoan Parasite Giardia lamblia(2008)19 cited
- → Discovery of ASTX029, A Clinical Candidate Which Modulates the Phosphorylation and Catalytic Activity of ERK1/2(2021)19 cited
- → Apo and Calcium-bound Crystal Structures of Alpha-11 Giardin, an Unusual Annexin from Giardia lamblia(2007)18 cited
- → Structural Biology and Anticancer Drug Design(2014)5 cited